Skip to main navigation Skip to search Skip to main content

β-endorphin in vitro inhibition of striatal dopamine release

  • Horace H. Loh
  • , David A. Brase
  • , Sumathy Sampath-Khanna
  • , Jeffrey B. Mar
  • , E. Leong Way
  • , Choh Hao Li

Research output: Contribution to journalArticlepeer-review

Abstract

THERE has been considerable recent interest in endogenous peptides as possible analgesic agents since the isolation of a pentapeptide with opiate-like activity (methionine-enkephalin) from porcine brain1. Of particular interest is β-endorphin, isolated from camel pituitary glands2, and now synthesised3. We report here the inhibitory effect in vitro of β-endorphin on striatal dopamine release from the central nervous system (CNS).

Original languageEnglish (US)
Pages (from-to)567-568
Number of pages2
JournalNature
Volume264
Issue number5586
DOIs
StatePublished - 1976

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'β-endorphin in vitro inhibition of striatal dopamine release'. Together they form a unique fingerprint.

Cite this